Pinealon is a synthetic, bioactive, tripeptide (Glu-Asp-Arg) derived from the pineal gland [3]. It is classified as a peptide bioregulator due to its unique ability to bypass typical cell-surface or cytoplasmic receptors [3]. Instead, evidence suggests that it’s exceptionally small structure enables the molecule to cross both cellular and nuclear membranes [3]. Lab studies find that Pinealon can enter the cell nucleus, where it is thought to interact with DNA or DNA-associated proteins [3]. This ability to reach the genome provides a potential explanation for its wide-ranging effects, which align better with gene-expression changes rather than modulating traditional signalling pathways [3].
Inside the nucleus, Pinealon seems to modulate genes involved in antioxidant defenses, cell repair, and protection from cellular stress [1]. Animal model research reveals reductions in reactive oxygen species and apoptosis, and increased activity of endogenous antioxidant enzymes [4]. It appears to reduce the activity of caspase-3, an enzyme involved in programmed cell death, across several tissue types, suggesting a potential role in supporting cell survival under stressful conditions [4]. Pinelon may impact pathways related to healthy cell cycling and interact with the pineal gland to influence its function and regulate circadian rhythm [5].
Its unique mechanism, which bypasses conventional cell-surface receptors, has led to growing interest in its potential roles in neuroprotection, metabolism, stress resilience, and cognitive support.
Through directly interacting with DNA to influence gene expression involved in neural function, Pinealon may support learning and memory. Studies suggest it can reduce oxidative stress in brain tissue, preserve neuronal viability, and modulate pathways related to information retention.
In a study of prenatal rats exposed to high levels of homocysteine, maternal administration of Pinealon improved offspring cognitive function, enhancing performance in spatial orientation and navigation tasks while reducing reactive oxygen species and neuronal necrosis in the cerebellum [6]. Another found Pinealon was able to produce improvements in the Morris labyrinth task, showing faster acquisition of navigation tasks compared to untreated controls and those treated with a comparator peptide [7]. Improvements were also accompanied by reductions in caspase-3 activity in brain regions, suggesting that this peptide supports neuronal survival and resilience under hypoxic stress [4].
In a review, authors highlight findings to suggest that Pinealon enhances learning indices, decreases age- and stress-related neuronal apoptosis, and improves overall memory performance in animal models. It is thought these benefits are related to Pinealon’s ability to penetrate the nucleus and modulate gene expression, upregulating protective pathways and antioxidant systems while stabilizing cell-cycle and cell-death processes [8].
Studies have found that Pinealon may help protect neurons through multiple and complementary mechanisms, primarily demonstrated in preclinical models. One major pathway involves reducing oxidative stress, a key contributor to neuronal injury and neurodegeneration. In cell studies, Pinealon was found to decrease ROS accumulation, reduce necrotic cell death, and modulate ERK1/2 activation, a signalling pathway involved in cell survival and stress response [1]. These findings suggest Pinealon may help maintain neuronal integrity under conditions of metabolic or oxidative stress, through direct genomic interactions that influence cell-cycle regulation [1].
Experimental hypoxia models further demonstrate neuroprotective effects. In hypobaric hypoxia and aged rat studies, Pinealon was able to increase neuronal resistance to oxygen deprivation, potentially by stimulating superoxide dismutase and glutathione peroxidase, and by limiting NMDA receptor-mediated excitotoxicity [7]. Pinealon was also found to normalize pro-inflammatory cytokines such as IL-6 and TNF‑α, indicating a dual role reducing programmed cell death and neuroinflammation [4].
At a molecular level, Pinealon is thought to modulate gene expression pathways associated with neurodegeneration [8]. Evidence suggests it can interact with histones and RNA, influencing pathways such as MAPK/ERK, as well as pro-apoptotic proteins and antioxidant genes [8]. This makes it a candidate for further study in neurodegenerative conditions.
Pinealon shows promise as an antioxidant and cellular longevity support. It supports brain cell viability by reducing reactive oxygen species (ROS) and limiting cell death, while also influencing cell survival pathways like ERK1/2 [1].
It also shows benefits for strengthening cell membranes and preventing lipid peroxidation, helping support the brain’s resistance to oxidative stress [8]. Pinealon has been shown to modulate the activity of antioxidant enzymes, including SOD and GPx, and support antioxidant genes like SOD2 and GPX1 [8]. In aging and low-oxygen models, it protects neurons by reducing excitotoxicity, lowering caspase‑3 activity, and normalizing inflammatory signals, which supports cell survival and new neuron growth [4].
In human neurons from older donors, it also reduces DNA damage and helps maintain dendritic structures [9]. Overall, Pinealon combines antioxidant, anti-aging, and anti-inflammatory effects, though human studies are still limited.
Research Use Only. All findings described above are derived from preclinical studies (animal models and in vitro experiments). Pinealon is not approved by the FDA for any diagnostic or therapeutic use in humans. Genesis Peptides makes no claims regarding human clinical efficacy. This product is sold exclusively for laboratory research.
Every lot undergoes five independent assays before release. Results are published in the lot-specific Certificate of Analysis.
Every lot undergoes our 4-panel testing protocol: HPLC purity analysis, ESI-MS identity confirmation, LAL endotoxin screening, and amino acid analysis (for peptides >15 residues). Full analytical data is published in the Certificate of Analysis for each lot.
Lyophilized peptides should be stored at -20°C or below for long-term stability. Once reconstituted, peptides should be stored at 2–8°C and used within a reasonable timeframe depending on the specific compound. Avoid repeated freeze-thaw cycles. Always store in a dry environment away from direct light.
Orders placed before noon PST, Monday–Saturday, ship the same day. We offer free standard shipping on orders over $150. All orders are shipped in insulated packaging with ice packs when necessary. Standard delivery typically takes 2–4 business days within the continental US.
No. All compounds sold by Genesis Peptides are strictly for in vitro and preclinical laboratory research purposes only. They are not approved for human consumption, therapeutic use, or diagnostic purposes. By purchasing, you confirm the products will be used solely for legitimate research applications.
A Certificate of Analysis (COA) is a document issued by our analytical laboratory that reports the results of all quality control tests performed on a specific lot of product. Each COA includes HPLC chromatograms, mass spectra, endotoxin results, and amino acid analysis where applicable. COAs are available in our COA Library for every lot we have shipped.
Yes. We offer volume pricing for universities, research institutions, and laboratories with recurring needs. Discounts begin at 10+ units and scale with volume. Contact our team for a custom quote tailored to your research requirements.
FOR RESEARCH USE ONLY — Products are sold exclusively for in vitro and preclinical laboratory research. Not for human consumption or administration. Not intended for diagnostic or therapeutic use. These statements have not been evaluated by the FDA.